This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Active Biotech Ab. Active years: 2006-2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oxfordshire, GB (2006)
- Abingdon, GB (2007)
Company Filing History:
Years Active: 2006-2007
Title: Chiara Ghiron: Innovator in Immunomodulatory Compounds
Introduction
Chiara Ghiron is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of immunomodulation, particularly through her innovative research and development of novel heterocyclic compounds. With a total of 2 patents to her name, Ghiron is recognized for her impactful work in medical treatments.
Latest Patents
Ghiron's latest patents focus on immunomodulatory compounds. These inventions relate to novel heterocyclic compounds, methods for their preparation, and compositions containing them. The patents detail methods and uses for clinical treatment of various medical conditions that may benefit from immunomodulation, including rheumatoid arthritis, multiple sclerosis, diabetes, asthma, transplantation, systemic lupus erythematosus, and psoriasis. More specifically, her inventions involve CD80 antagonists capable of inhibiting the interactions between CD80 and CD28.
Career Highlights
Chiara Ghiron has established herself as a key figure in her field through her innovative research. Her work has the potential to transform treatment options for patients suffering from chronic and autoimmune diseases. Ghiron's dedication to advancing medical science is evident in her patent filings and ongoing research efforts.
Collaborations
Ghiron has collaborated with notable colleagues, including Ian Richard Matthews and Chris James Brennan. These partnerships have contributed to her success and the advancement of her research initiatives.
Conclusion
Chiara Ghiron is a trailblazer in the development of immunomodulatory compounds, with a focus on innovative treatments for various medical conditions. Her contributions to the field are significant and continue to influence the landscape of medical research and treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
